Manufacturing
Established in 2009, BF Biosciences operates Pakistan’s first biopharmaceutical manufacturing facility, designed in line with EU and US FDA standards by Telstar Projects
Since 2009
Operational manufacturing facility
2 Production Lines
Biological & non-biological capabilities
3 Delivery Formats
Vials · Ampoules Prefilled Syringes
EU & US FDA-aligned Design
Designed by Telstar Projects
BF Biosciences established its manufacturing facility in 2009 to bring specialized biological medicines closer to patients in Pakistan. Initially focused on low-volume treatments for Hepatitis C, Cancer and Chronic Kidney Disease, the facility also supported the production of selected non-biological medicines.
By manufacturing locally, BF Biosciences has helped improve access to critical therapies, reduce reliance on imports and strengthen Pakistan’s biopharmaceutical manufacturing capabilities.
Our manufacturing infrastructure combines the flexibility required for specialized low-volume products with expanded high-speed capabilities for a broader biological and non-biological portfolio
Operational since 2009
Completed in 2024
High-speed Combi Line
Syntegon Technology, Germany
Large-volume Lyophilizer
Telstar
High-speed Prefilled Syringe Line
Syntegon Technology, Germany
Purpose-built environments, advanced manufacturing technologies and highly controlled production areas
Showing image 1 of 17: Production hall with stainless-steel process equipment at the BF Biosciences facility
Quality Assurance & Control
Quality is integrated into the facility, its processes and its analytical infrastructure— from cleanroom design and equipment qualification to microbiological control and laboratory testing.
Certifications
ISO 9001
Quality Management
ISO 14001
Environmental Management
ISO 45001
Occupational Health & Safety
ISO 17025
Laboratory Competence
Leverage our decades of pharmaceutical manufacturing expertise, state-of-the-art facilities, and global quality frameworks for your contract manufacturing needs.
Get in touch
